Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367601089> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4367601089 abstract "Treatment-resistant depression (TRD) is a major public health problem worldwide. There are currently five strategies for its treatment: optimization, change, combination, augmentation, and somatic therapies. However, many of these therapies are not fully effective, are not accessible, or have a significant number of side effects. Esketamine nasal spray has recently been approved, in combination with another oral antidepressant, for TRD, with excellent results in short-term studies. We consider in this review whether this therapy is also safe and effective in the long-term treatment of patients. A narrative review, using a comprehensive Pubmed search, and other search strategies, of long-term studies evaluating the safety and efficacy of esketamine nasal spray for the treatment of TRD has been conducted. Five studies have been included in the review. Esketamine nasal spray has demonstrated long-term efficacy and safety in both placebo-controlled and open-label studies evaluating maintenance of antidepressant response. In addition, one study has reported a high level of patient satisfaction with treatment. As limitations, a systematic search for studies has not been carried out and these are still scarce, given the short time that has elapsed since the discovery of the molecule. Esketamine nasal spray is the greatest pharmacological novelty in the treatment of major depression in the last 50 years. It constitutes a new paradigm in the treatment of TRD, which should make us rethink the care protocols that we currently follow. However, more studies are still needed to consolidate the data found so far. (PsycInfo Database Record (c) 2023 APA, all rights reserved)." @default.
- W4367601089 created "2023-05-02" @default.
- W4367601089 creator A5034565820 @default.
- W4367601089 date "2023-05-01" @default.
- W4367601089 modified "2023-09-30" @default.
- W4367601089 title "Changing the paradigm in treatment-resistant depression: A review of long-term efficacy and tolerability of esketamine nasal spray." @default.
- W4367601089 doi "https://doi.org/10.1037/pha0000650" @default.
- W4367601089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37126036" @default.
- W4367601089 hasPublicationYear "2023" @default.
- W4367601089 type Work @default.
- W4367601089 citedByCount "0" @default.
- W4367601089 crossrefType "journal-article" @default.
- W4367601089 hasAuthorship W4367601089A5034565820 @default.
- W4367601089 hasConcept C118552586 @default.
- W4367601089 hasConcept C126322002 @default.
- W4367601089 hasConcept C17744445 @default.
- W4367601089 hasConcept C177713679 @default.
- W4367601089 hasConcept C197934379 @default.
- W4367601089 hasConcept C199539241 @default.
- W4367601089 hasConcept C2777342061 @default.
- W4367601089 hasConcept C2778375690 @default.
- W4367601089 hasConcept C2779177272 @default.
- W4367601089 hasConcept C2779473830 @default.
- W4367601089 hasConcept C2779549880 @default.
- W4367601089 hasConcept C2780051608 @default.
- W4367601089 hasConcept C2780733359 @default.
- W4367601089 hasConcept C2780973058 @default.
- W4367601089 hasConcept C558461103 @default.
- W4367601089 hasConcept C71924100 @default.
- W4367601089 hasConcept C85663871 @default.
- W4367601089 hasConcept C98274493 @default.
- W4367601089 hasConceptScore W4367601089C118552586 @default.
- W4367601089 hasConceptScore W4367601089C126322002 @default.
- W4367601089 hasConceptScore W4367601089C17744445 @default.
- W4367601089 hasConceptScore W4367601089C177713679 @default.
- W4367601089 hasConceptScore W4367601089C197934379 @default.
- W4367601089 hasConceptScore W4367601089C199539241 @default.
- W4367601089 hasConceptScore W4367601089C2777342061 @default.
- W4367601089 hasConceptScore W4367601089C2778375690 @default.
- W4367601089 hasConceptScore W4367601089C2779177272 @default.
- W4367601089 hasConceptScore W4367601089C2779473830 @default.
- W4367601089 hasConceptScore W4367601089C2779549880 @default.
- W4367601089 hasConceptScore W4367601089C2780051608 @default.
- W4367601089 hasConceptScore W4367601089C2780733359 @default.
- W4367601089 hasConceptScore W4367601089C2780973058 @default.
- W4367601089 hasConceptScore W4367601089C558461103 @default.
- W4367601089 hasConceptScore W4367601089C71924100 @default.
- W4367601089 hasConceptScore W4367601089C85663871 @default.
- W4367601089 hasConceptScore W4367601089C98274493 @default.
- W4367601089 hasFunder F4320322930 @default.
- W4367601089 hasLocation W43676010891 @default.
- W4367601089 hasLocation W43676010892 @default.
- W4367601089 hasOpenAccess W4367601089 @default.
- W4367601089 hasPrimaryLocation W43676010891 @default.
- W4367601089 hasRelatedWork W1969236408 @default.
- W4367601089 hasRelatedWork W2049129528 @default.
- W4367601089 hasRelatedWork W2098097322 @default.
- W4367601089 hasRelatedWork W2099749043 @default.
- W4367601089 hasRelatedWork W2156439264 @default.
- W4367601089 hasRelatedWork W2342584978 @default.
- W4367601089 hasRelatedWork W2945361245 @default.
- W4367601089 hasRelatedWork W4321367679 @default.
- W4367601089 hasRelatedWork W4385668042 @default.
- W4367601089 hasRelatedWork W2183331092 @default.
- W4367601089 isParatext "false" @default.
- W4367601089 isRetracted "false" @default.
- W4367601089 workType "article" @default.